Chen Chong, Zhang Shu-Ye, Chen Liang
Department of Infectious Disease, Shanghai Public Health Clinical Center, Fudan University, Shanghai 201508, China.
Department of Hepatology, Shanghai Public Health Clinical Center, Shanghai 201508, China.
World J Clin Cases. 2022 Jul 6;10(19):6341-6348. doi: 10.12998/wjcc.v10.i19.6341.
Hepatitis E virus (HEV) is the most common cause of acute liver failure (LF) and one of the most common factors causing acute injury in acute-on-chronic LF (ACLF). When HEV-related LF occurs, a series of changes take place in both the intrahepatic environment and extrahepatic microenvironment. The changed types and distribution of immune cells (infiltrating macrophages and increased lymphocytes) in liver tissue, as well the increased proinflammatory cytokines and chemokines in the blood, indicate that the occurrence and progression of HEV-related LF are closely related to immune imbalance. The clinical features and immune reaction in the body during HEV-related acute LF (ALF) and ACLF are complicated. This review highlights recent progress in elucidating the clinical manifestations of HEV-associated ALF and ACLF and discusses the corresponding systemic immune changes and possible regulatory mechanisms.
戊型肝炎病毒(HEV)是急性肝衰竭(LF)最常见的病因,也是导致慢加急性肝衰竭(ACLF)急性损伤的最常见因素之一。当发生与HEV相关的肝衰竭时,肝内环境和肝外微环境都会发生一系列变化。肝组织中免疫细胞(浸润性巨噬细胞和淋巴细胞增多)类型和分布的改变,以及血液中促炎细胞因子和趋化因子的增加,表明与HEV相关的肝衰竭的发生和进展与免疫失衡密切相关。与HEV相关的急性肝衰竭(ALF)和ACLF期间的临床特征及体内免疫反应较为复杂。本文综述重点介绍了在阐明与HEV相关的ALF和ACLF临床表现方面的最新进展,并讨论了相应的全身免疫变化及可能的调节机制。